Jump to content

Recommended Posts

Posted

I'm interviewing for an enzymologist position at a pharma company. So the keys here are models of inhibition and assay design.

Although I have some experience setting up kinetics assays, it was in a different context and with little/no support or criticism from anyone in my company. My questions are:

  • When would one choose an endpoint assay over a continuous/real time one?
  • In a kinase assay, what are some ADvantages of measuring ADP over the phosphorylated substrate?
  • When would you choose a linearized plot (eg Lineweaver Burke, Eadie Hofstee) over a non linear plot?
  • How would dose-response data on a semi-log vs. linear scale look?

Thanks in advance.

 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.